Dual Strong Cyp3a4 / Moderate Cyp1a2 Inducers has 3 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Siponimod, Diazoxide Choline, Roflumilast. Patients taking Dual Strong Cyp3a4 / Moderate Cyp1a2 Inducers should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 1
- Moderate
- 2
Major (1)
- Dual Strong Cyp3a4 / Moderate Cyp1a2 Inducers + Siponimod— Dual moderate CYP2C9/strong CYP3A4 inducers decrease siponimod exposure; concomitant use is not recommended.
Moderate (2)
- Dual Strong Cyp3a4 / Moderate Cyp1a2 Inducers + Diazoxide Choline— Concomitant use not recommended as it may decrease VYKAT XR exposure and efficacy.
- Dual Strong Cyp3a4 / Moderate Cyp1a2 Inducers + Roflumilast— Co-administration may increase roflumilast systemic exposure and may result in increased adverse reactions. Weigh potent…